# CYTOMED THERAPEUTICS LIMITED SHS

CYTOMED THERAPEUTICS LIMITED SHS is a security (CUSIP Y1R80M106) tracked across SEC portfolio filings. 5 institutional managers reported $24K on Form 13F as of 2026-06-30.

## Summary

- Issuer: CYTOMED THERAPEUTICS LIMITED
- Class: SHS
- CUSIP: Y1R80M106
- 13F holders: 5
- 13F value: $24K
- 13F period: 2026-06-30
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| XTX Topco Ltd | LONDON, X0 | $10K | 10,136 |
| [Axiom Investment Management LLC](https://search.stillhousedata.com/firm/141516) | NEW YORK, NY | $7K | 7,032 |
| UBS Group AG | Zurich, V8 | $6K | 6,182 |
| OSAIC HOLDINGS, INC. | PHOENIX, AZ | $21 | 21 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/Y1R80M106.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.